SCHEMBL20592176

SCHEMBL20592176

CC(C)(O)CN1CCC(Nc2ccc(C(=O)Nc3ccccc3N)cc2)C1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HDAC2 Q92769 6/20 0.58
▸ HDAC1 Q13547 16/20 0.50
▸ HDAC3 O15379 6/20 0.50
▸ HDAC4 P56524 3/20 0.50
▸ HDAC7 Q8WUI4 3/20 0.50
▸ HDAC10 Q969S8 3/20 0.50
▸ HDAC11 Q96DB2 3/20 0.50
▸ HDAC8 Q9BY41 3/20 0.50
▸ HDAC6 Q9UBN7 3/20 0.50
▸ HDAC9 Q9UKV0 3/20 0.50
▸ HDAC5 Q9UQL6 3/20 0.50
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ NCOR2 Q9Y618 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18361055 1.00 HDAC2 (0.58) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL18361349 1.00 HDAC2 (0.58) HDAC2HDAC1HDAC3HDAC4HDAC7
Hydrochloric Acid SCHEMBL20592187 0.99 HDAC2 (0.57) HDAC2HDAC1HDAC3HDAC4HDAC7
Hydrochloric Acid SCHEMBL20592190 0.99 HDAC2 (0.57) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL18361309 0.94 HDAC2 (0.60) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL18361390 0.93 HDAC1 (0.51) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL18361253 0.93 HDAC1 (0.51) HDAC2HDAC1HDAC3HDAC4HDAC7
SCHEMBL20592170 0.93 HDAC1 (0.51) HDAC2HDAC1HDAC3HDAC4HDAC7
Hydrochloric Acid SCHEMBL20592213 0.92 HDAC1 (0.50) HDAC2HDAC1HDAC3HDAC4HDAC7
Hydrochloric Acid SCHEMBL20592216 0.92 HDAC1 (0.50) HDAC2HDAC1HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210009519-A1 HISTONE DEACETYLASE INHIBITORS BIOMARIN PHARMACEUTICAL INC. 2021-01-14 — — US disclosed
US-10851058-B2 Histone deacetylase inhibitors BIOMARIN PHARMACEUTICAL INC. (US) 2020-12-01 — — US disclosed
US-10308608-B2 Histone deacetylase inhibitors BIOMARIN PHARMACEUTICAL INC. (US) 2019-06-04 — — US disclosed
US-20180370915-A1 HISTONE DEACETYLASE INHIBITORS BIOMARIN PHARMACEUTICAL INC. 2018-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10851058-B2 Histone deacetylase inhibitors HDAC1, HDAC2, HDAC3 HDAC2 2/4885HDAC1 1/4885HDAC3 3/4885
US-20210009519-A1 HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC2, HDAC3 HDAC2 2/4885HDAC1 1/4885HDAC3 3/4885
US-20180370915-A1 HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC2, HDAC3 HDAC2 2/4885HDAC1 1/4885HDAC3 3/4885
US-10308608-B2 Histone deacetylase inhibitors HDAC1, HDAC2, HDAC3 HDAC2 2/4885HDAC1 1/4885HDAC3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback